Leo Price is a biotech entrepreneur and the founder of OcellO, a contract research organization that offered innovative phenotypic screening and compound profiling services until its acquisition by Crown Biosciences in April 2021. Leo currently serves as a Scientific Advisory Board member at Crown Biosciences and continues to lead OcellO's unique services within the organization. Additionally, Leo is a co-founder and Advisory Board member of both VitroScan and Imuno Therapeutics, which focus on advanced drug testing and precision immunotherapies respectively. Leo's academic contributions include serving as a guest associate professor at the Leiden Academic Centre for Drug Research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices